VNBTrust National Association held its stake in shares of Clorox Co. (NYSE:CLX) during the second quarter, Holdings Channel reports. The firm owned 1,934 shares of the company’s stock at the end of the second quarter. VNBTrust National Association’s holdings in Clorox were worth $267,000 as of its most recent filing with the SEC.
A number of other large investors have also made changes to their positions in CLX. Invictus RG acquired a new stake in shares of Clorox during the first quarter worth $110,000. Checchi Capital Advisers LLC boosted its stake in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Mutual of Omaha Bank Wealth Management boosted its stake in shares of Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock worth $226,000 after buying an additional 300 shares during the period. Paragon Capital Management Ltd acquired a new stake in shares of Clorox during the second quarter worth $232,000. Finally, Sii Investments Inc. WI boosted its stake in shares of Clorox by 29.8% in the first quarter. Sii Investments Inc. WI now owns 2,115 shares of the company’s stock worth $267,000 after buying an additional 485 shares during the period. Institutional investors and hedge funds own 70.27% of the company’s stock.
Shares of Clorox Co. (NYSE:CLX) traded up 0.14% on Wednesday, reaching $126.02. 458,794 shares of the company were exchanged. The stock has a market capitalization of $16.32 billion, a price-to-earnings ratio of 25.61 and a beta of 0.33. The firm’s 50 day moving average price is $128.61 and its 200 day moving average price is $130.12. Clorox Co. has a 52 week low of $114.06 and a 52 week high of $140.47.
Clorox (NYSE:CLX) last released its earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.28 by $0.02. The company earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the business earned $1.44 earnings per share. Equities research analysts anticipate that Clorox Co. will post $5.49 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 2.54%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is presently 64.91%.
CLX has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $148.00 target price on the stock in a research note on Monday, August 8th. Atlantic Securities upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 target price on the stock in a research note on Friday, September 16th. Jefferies Group reiterated a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Deutsche Bank AG reiterated a “hold” rating and issued a $134.00 target price (up previously from $130.00) on shares of Clorox in a research note on Sunday, July 24th. Finally, B. Riley reiterated a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research note on Tuesday, August 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $128.90.
In related news, COO Nikolaos A. Vlahos sold 925 shares of Clorox stock in a transaction that occurred on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Laura Stein sold 38,882 shares of Clorox stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The disclosure for this sale can be found here. 2.09% of the stock is currently owned by corporate insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.